Skip to content

Superior Bilioenteric Anastomosis by Magnetic Compressive Technique

Superior Bilioenteric Anastomosis by Magnetic Compressive Technique: A Multicenter, Prospective, Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02801500
Acronym
CTREG
Enrollment
70
Registered
2016-06-16
Start date
2017-07-01
Completion date
2019-06-30
Last updated
2017-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Injury, Biliary Calculi, Choledochal Cyst, Hilar Cholangiocarcinoma

Keywords

bilioenteric anastomosis

Brief summary

The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on superior bilioenteric anastomosis.

Detailed description

The superior bilioenteric anastomosis is one of the most common and difficult operations in Hepatobiliary Surgery. The traditional manual anastomosis has become one of the main prognosis factors because of the length of suture time, the difficulty of operation, the high incidence of anastomotic leakage and stricture. Magnetic compressive anastomosis can realize the fast anastomosis, reduce the difficulty, and reduce the incidence of anastomotic leakage and stricture. Currently, the majority of studies of magnetic compressive bilioenteric anastomosis are merely confined within clinical case report and single-center, small sample, retrospective study, thus they are lack of convictive evidence of evidence-based medicine for the security, reliability and convince. This study is a multicenter, prospective, randomized controlled trial. To evaluate the security, reliability and convince of magnetic compressive superior bilioenteric anastomosis, this study compared the incidence of anastomotic leakage and stricture between magnetic compressive anastomosis and traditional manual anastomosis among patients who need superior bilioenteric anastomosis operation. The study design plan to enroll 70 patients and divide into Study Group (Group A: Magnetic compressive anastomosis) and Control Group (Group B: traditional manual anastomosis) as 1:1 ratio randomly by stratification factors. The incidence of anastomotic leakage and stricture, length of bilioenteric anastomosis time, value of serum bilirubin, length of discharge time of magnetic device and mean time of hospital stay will be evaluated. The patients will drop out of the study if adverse events happen, active request for dropping out, new-onset severe disease or death. The primary and secondary end point will be observed by regular follow-up.

Interventions

The magnetic compressive anastomosis device will be used to complete the anastomosis during bilioenteric anastomosis.

A handsewn technique will be used to complete the anastomosis during bilioenteric anastomosis.

Sponsors

Shaanxi Provincial People's Hospital
CollaboratorOTHER
Tang-Du Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
First Affiliated Hospital of Xinjiang Medical University
CollaboratorOTHER
General Hospital of Ningxia Medical University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with age between 18 to 75 * Patients' gender was not limited * Patients who were well-diagnosed and had the indication for superior bilioenteric anastomosis. * Patients whose lifetimes will be longer than 12 months. * Patients who are willing to join this clinical trial and informed consent form voluntarily.

Exclusion criteria

* Woman during pregnancy or lactation or anyone with mental disorder * The wall of hepatic duct or jejunum was too thick so that the attractive force of magnetic device cannot meet the requirements of compression. * Any anatomical variation in bile ducts system or the inner diameter is too small so that the magnetic device cannot place in. * Any foreign body has been implanted in body, such as heart pacemaker. * Surgical contraindication, including: Child-Pugh C with hepatic encephalopathy Anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery.Hepatic ducts stone disease, who was diagnosed as Acute Cholangitis of Severe Type, especially complicated with bacteremia or septic shock. End stage disease, complicated with biliary cirrhosis or portal hypertension.Patients with long-term obstructive jaundice, dehydration, electrolyte disturbance or coagulation defects; Patients have the tendency or history of bleeding. * Any other disease in perioperation periods which needs MRI examination in the next 8 weeks post operation.

Design outcomes

Primary

MeasureTime frame
Bilioenteric anastomotic leakage1 month post operation

Secondary

MeasureTime frame
Number of patients who have discharged the device on the date expected.1 to 4 weeks postoperation
Number of patients who have been diagnosed as discharge disorder of magnetic deviceless than 1 week or more than 4 weeks
Length of bilioenteric anastomosis timeduring operation
Times of pathological examination of bile duct's remnant of Klatskin' tumorduring operation
Bilioenteric anastomotic strictureTime Frame: 1,3,6,12-month post operation
average length of postoperative hospital stay3 months

Countries

China

Contacts

Primary ContactYi Lv, MD,PHD
luyi169@126.com0086-13991200581

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026